Shares of Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) fell 7.7% during mid-day trading on Tuesday . The company traded as low as $14.80 and last traded at $14.82. 49,762 shares changed hands during trading, a decline of 73% from the average session volume of 181,088 shares. The stock had previously closed at $16.05.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on ARDT shares. Royal Bank of Canada reissued an "outperform" rating and set a $23.00 price objective on shares of Ardent Health Partners in a report on Thursday, November 14th. Bank of America cut shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Stephens restated an "overweight" rating and set a $24.00 price target on shares of Ardent Health Partners in a research report on Thursday, September 19th. Leerink Partners upped their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a report on Tuesday, November 12th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and set a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $22.00.
Read Our Latest Research Report on Ardent Health Partners
Ardent Health Partners Price Performance
The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The stock's 50-day moving average is $16.53.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets purchased a new position in shares of Ardent Health Partners during the 3rd quarter worth approximately $42,000. Financial Management Professionals Inc. purchased a new position in Ardent Health Partners during the 3rd quarter valued at about $50,000. MetLife Investment Management LLC bought a new stake in Ardent Health Partners during the third quarter worth about $135,000. JPMorgan Chase & Co. purchased a new stake in Ardent Health Partners in the third quarter worth about $154,000. Finally, Quadrature Capital Ltd bought a new position in shares of Ardent Health Partners during the third quarter valued at approximately $229,000.
About Ardent Health Partners
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Recommended Stories
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
